ONE Bio Corp. (ONBI)
OTCMKTS
· Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: May 2, 2025
ONE Bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2010 | FY 2009 | FY 2008 | FY 2007 | FY 2006 | 2004 - 2005 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '11 Sep 30, 2011 | Dec '10 Dec 31, 2010 | Dec '09 Dec 31, 2009 | Dec '08 Dec 31, 2008 | Dec '07 Dec 31, 2007 | Dec '06 Dec 31, 2006 | 2004 - 2005 |
| Operating Revenue | 53.91 | 52.3 | 22.07 | 10.4 | 0.14 | 0.21 | Upgrade
|
| Other Revenue | - | - | - | - | - | 0 | Upgrade
|
| Revenue | 53.91 | 52.3 | 22.07 | 10.4 | 0.14 | 0.21 | Upgrade
|
| Revenue Growth (YoY) | 6.13% | 136.92% | 112.21% | 7250.54% | -31.81% | 26.70% | Upgrade
|
| Cost of Revenue | 30.24 | 32.17 | 12.09 | 3.94 | 0.08 | 0.14 | Upgrade
|
| Gross Profit | 23.67 | 20.13 | 9.98 | 6.46 | 0.07 | 0.06 | Upgrade
|
| Selling, General & Admin | 8.14 | 6.18 | 2.15 | 1.37 | 0.07 | 0.05 | Upgrade
|
| Research & Development | 0.37 | 0.26 | 0.38 | 0.44 | - | - | Upgrade
|
| Other Operating Expenses | - | - | - | - | 0 | 0 | Upgrade
|
| Operating Expenses | 8.52 | 6.44 | 2.53 | 1.81 | 0.09 | 0.08 | Upgrade
|
| Operating Income | 15.15 | 13.68 | 7.46 | 4.65 | -0.02 | -0.01 | Upgrade
|
| Interest Expense | -1.33 | -0.74 | -0.23 | -0.15 | -0.01 | -0 | Upgrade
|
| Interest & Investment Income | 0.07 | 0.03 | 0.04 | 0.01 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0.28 | -0.74 | 0.15 | 0.06 | - | - | Upgrade
|
| EBT Excluding Unusual Items | 13.61 | 12.24 | 7.41 | 4.57 | -0.03 | -0.02 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | 0 | 0.01 | Upgrade
|
| Other Unusual Items | - | - | - | - | -0 | - | Upgrade
|
| Pretax Income | 12.87 | 12.24 | 7.41 | 4.57 | -0.03 | -0 | Upgrade
|
| Income Tax Expense | 3.9 | 3.28 | 2.03 | 1.22 | - | 0 | Upgrade
|
| Earnings From Continuing Operations | 8.97 | 8.96 | 5.38 | 3.35 | -0.03 | -0 | Upgrade
|
| Minority Interest in Earnings | -0.03 | -0.28 | -0.61 | - | - | - | Upgrade
|
| Net Income | 8.94 | 8.68 | 4.77 | 3.35 | -0.03 | -0 | Upgrade
|
| Net Income to Common | 8.94 | 8.68 | 4.77 | 3.35 | -0.03 | -0 | Upgrade
|
| Net Income Growth | 3.96% | 81.79% | 42.46% | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 7 | 6 | 5 | 5 | 4 | 4 | Upgrade
|
| Shares Outstanding (Diluted) | 7 | 6 | 5 | 5 | 4 | 4 | Upgrade
|
| Shares Change (YoY) | 15.87% | 25.54% | 8.74% | 15.77% | 1.79% | 6.49% | Upgrade
|
| EPS (Basic) | 1.30 | 1.43 | 0.95 | 0.71 | -0.01 | -0.00 | Upgrade
|
| EPS (Diluted) | 1.22 | 1.35 | 0.93 | 0.71 | -0.01 | -0.00 | Upgrade
|
| EPS Growth | -10.66% | 45.16% | 30.99% | - | - | - | Upgrade
|
| Free Cash Flow | 11.3 | 5.03 | 3.43 | 1.7 | -0 | -0.03 | Upgrade
|
| Free Cash Flow Per Share | 1.55 | 0.78 | 0.67 | 0.36 | -0.00 | -0.01 | Upgrade
|
| Gross Margin | 43.90% | 38.48% | 45.23% | 62.13% | 46.72% | 30.95% | Upgrade
|
| Operating Margin | 28.11% | 26.16% | 33.79% | 44.72% | -14.65% | -5.47% | Upgrade
|
| Profit Margin | 16.58% | 16.59% | 21.62% | 32.21% | -18.66% | -1.82% | Upgrade
|
| Free Cash Flow Margin | 20.95% | 9.62% | 15.52% | 16.37% | -2.29% | -13.67% | Upgrade
|
| EBITDA | 16.07 | 14.32 | 7.84 | 4.92 | -0.01 | 0.01 | Upgrade
|
| EBITDA Margin | 29.80% | 27.39% | 35.52% | 47.31% | -4.44% | 4.29% | Upgrade
|
| D&A For EBITDA | 0.92 | 0.64 | 0.38 | 0.27 | 0.01 | 0.02 | Upgrade
|
| EBIT | 15.15 | 13.68 | 7.46 | 4.65 | -0.02 | -0.01 | Upgrade
|
| EBIT Margin | 28.11% | 26.16% | 33.79% | 44.72% | -14.65% | -5.47% | Upgrade
|
| Effective Tax Rate | 30.30% | 26.82% | 27.35% | 26.74% | - | - | Upgrade
|
| Revenue as Reported | - | - | - | - | 0.14 | 0.21 | Upgrade
|
| Advertising Expenses | - | - | - | - | 0.02 | 0.01 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.